Discoveries in Rheumatoid Arthritis

WASHINGTON — Healio spoke with Jeffrey A. Sparks, MD, MMSc, about baseline results from the SAIL-RA study, which assesses which patients with rheumatoid arthritis may be at risk for developing interstitial lung disease.

WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, highlights an observational study investigating the impact of disease-modifying antirheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.

WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, discusses two translational studies focused on human tissue for the treatment of rheumatoid arthritis.

SAN DIEGO — In this Healio video, Jeffrey A. Sparks, MD, MMSc, highlighted studies from members of his group at Brigham and Women’s Hospital that were presented at ACR Convergence 2023.

SAN DIEGO — In this video, Jeffrey A. Sparks, MD, MMSc, spoke with Healio about the safety of TNF inhibitors compared with alternative targeted therapies for patients with rheumatoid arthritis-associated interstitial lung disease.

SAN DIEGO — In this Healio video, Jeffrey A. Sparks, MD, MMSc, discusses results from a proof-of-concept study that assessed the efficacy of administering medication for rheumatoid arthritis into the peripheral lymphatic systems.

SAN DIEGO — Jeffrey A. Sparks, MD, MMSc, spoke with Healio about two “high-impact” presentations from ACR Convergence 2023 that assessed dosing of prednisone for patients with rheumatoid arthritis.

SAN DIEGO — In this video, Healio spoke with Jeffrey A. Sparks, MD, MMSc, results from a study conducted in India assessing the efficacy of treating rheumatoid arthritis with split-doses of methotrexate.

SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a presentation from ACR Convergence 2023 that assessed the impact of diet on patients with rheumatoid arthritis and lupus.

SAN DIEGO — In this video, Kathryn Dao, MD, spoke with Healio about patient-reported outcomes from the ARCTIC REWIND study presented at ACR Convergence 2023.